Since studies are lacking, it remains unclear whether certain patients have a benefit if the decision for or against adjuvant chemotherapy is based on the concentration of uPA and PAI-1, a new report states.
Since studies are lacking, it remains unclear whether certain patients have a benefit if the decision for or against adjuvant chemotherapy is based on the concentration of uPA and PAI-1, a new report states.